1-3 of 3
Cristina Pérez
Close
Sort by
Journal Articles

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Francisco Cervantes, Pilar López-Garrido, María-Isabel Montero, Fermín Jonte, Jesus Martinez, Juan-Carlos Hernández-Boluda, MD, PhD, María Calbacho, Anna Sureda, MD, PhD, Gloria Pérez-Rus, José Nieto, MD, Cristina Pérez-López, José Román, Marcos González, Arturo Pereira, Dolors Colomer
Journal: Blood
Blood (2009) 114 (22): 1113.
https://doi.org/10.1182/blood.V114.22.1113.1113
Published: 2009
Journal Articles

Value of Gene Expression Profiling by Taqman® Low Density Arrays in the Diagnosis and Prognosis of Acute Myeloid Leukemia.

Carmen Chillon, Carlos Santamaria, Ramon Garcia-Sanz, Montserrat Hernandez, Norma C. Gutiérrez, Dolores Caballero, Maria-Belén Vidriales, Cristina Pérez, Ana Balanzategui, Miguel Alcoceba, Maria E. Sarasquete, Noemi Puig, Fernando Ramos, Alfonso García de Coca, Joaquin Díaz-Mediavilla, J.F San Miguel, Marcos Gonzalez
Journal: Blood
Blood (2009) 114 (22): 1620.
https://doi.org/10.1182/blood.V114.22.1620.1620
Published: 2009
Journal Articles

ERG, EVI1 and PRAME Are Relevant Markers of Treatment Response and Survival, and They Could Be Useful for Improving the Risk-Stratification in Citogenetically Normal Acute Myeloid Leukemia (CN-AML)

Carlos Santamaría, Carmen Chillón, Ramon García-Sanz, Cristina Pérez, Fernando Ramos, Alfonso García de Coca, Jose- Maria Alonso, Pilar Giraldo, Teresa Bernal, José-Antonio Queizán, José Nicolas Rodríguez, Pascual Fernández-Abellán, Abelardo Barez, María-José Peñarrubia, Mari Luz Amigo, Alejandro Martín García-Sancho, Miguel Angel Pozas, Ana Balanzategui, Joaquin Díaz-Mediavilla, Jesús F. San Miguel, Marcos González
Journal: Blood
Blood (2008) 112 (11): 4844.
https://doi.org/10.1182/blood.V112.11.4844.4844
Published: 2008